Intraocular lens explantation or exchange: indications, postoperative interventions, and outcomes

Basit Öğe Kaydı
dc.authoridSatirtav, Gunhal/0000-0003-4157-2876
dc.authoridKerimoglu, Hurkan/0000-0002-5601-2049
dc.authoridOzkagnici, Ahmet/0000-0001-7411-2484
dc.contributor.authorOltulu, Refik
dc.contributor.authorErsan, Ismail
dc.contributor.authorSatirtav, Gunhal
dc.contributor.authorDonbaloglu, Meryem
dc.contributor.authorKerimoglu, Hurkan
dc.contributor.authorOzkagnici, Ahmet
dc.date.accessioned2025-01-27T20:25:05Z
dc.date.available2025-01-27T20:25:05Z
dc.date.issued2015
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractPurpose: To analyze the indications for explantation or exchange of intraocular lenses (IOLs), which were originally implanted for the correction of aphakia during cataract extraction. Methods: All cases that involved intraocular lens explantation or exchange in one institution between January 2008 and December 2014 were analyzed retrospectively. Results: In total, 93 eyes of 93 patients were analyzed. The median time interval between implantation and explantation of the anterior chamber intraocular lenses (AC IOL) and posterior chamber intraocular lenses (PC IOL) was 83.40 +/- 83.14 months (range: 1-276 months) and 55.14 +/- 39.25 months (range: 1-168 months), respectively. Pseudophakic bullous keratopathy (17 eyes, 38.6%) and persistent iritis (12 eyes, 27.8%) in the AC IOL group and dislocation or decentration (30 eyes, 61.2%) and incorrect IOL power (nine eyes, 18.4%) in the PC IOL group were the most common indications for explantation of IOLs. The mean logMAR best corrected visual acuity (BCVA) improved significantly from 1.30 preoperatively to 0.62 postoperatively in the PC IOL group (p<0.001) but did not improve significantly in the AC IOL group (p=0.186). Conclusions: The primary indication for IOL explantation or exchange was pseudophakic bullous keratopathy in the AC IOL group and was dislocation or decentration in the PC IOL group. PC IOL explantation or exchange is safe and improves visual acuity.
dc.identifier.doi10.5935/0004-2749.20150040
dc.identifier.endpage157
dc.identifier.issn0004-2749
dc.identifier.issn1678-2925
dc.identifier.issue3
dc.identifier.pmid26222103
dc.identifier.scopus2-s2.0-84938088305
dc.identifier.scopusqualityQ3
dc.identifier.startpage154
dc.identifier.urihttps://doi.org/10.5935/0004-2749.20150040
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22428
dc.identifier.volume78
dc.identifier.wosWOS:000358772000005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherConsel Brasil Oftalmologia
dc.relation.ispartofArquivos Brasileiros De Oftalmologia
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectCataract extraction
dc.subjectLenses
dc.subjectintraocular
dc.subjectReoperation
dc.subjectDevice removal
dc.subjectLens implantation
dc.subjectintraocular
dc.subjectPseudophakia
dc.subjectCorneal diseases
dc.subjectPatient satisfaction
dc.subjectVisual acuity
dc.titleIntraocular lens explantation or exchange: indications, postoperative interventions, and outcomes
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu